Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Two of three patients with multiple chemical sensitivity had less symptoms and secondary hyperalgesia after transcranially applied pulsed electromagnetic fields

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Chronic pain after bilateral thoracotomy in lung transplant patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Itch sensitization? A systematic review of studies using quantitative sensory testing in patients with chronic itch

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Classification and treatment of itch

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Assessing Punctate Administration of Beta-alanine as a Potential Human Model of Non-histaminergic Itch

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Alloknesis and hyperknesis-mechanisms, assessment methodology, and clinical implications of itch sensitization

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background Multiple chemical sensitivity (MCS) is a chronic, disabling condition characterized by recurrent multisystem symptoms triggered by common airborne chemicals. Evidence points towards abnormal sensory processing in the central nervous system (CNS) as a likely pathophysiological mechanism. No effective treatment has yet been reported, but clinical observations suggest that as pulsed electromagnetic fields (PEMF) is a treatment for some CNS disorders (depression and chronic pain), it may also be a treatment modality for MCS. Methods In an open case study, the effects of PEMF were assessed in three MCS patients. All cases received 30 min daily treatment 5 days a week for 8 consecutive weeks. Symptoms and functional impairments related to MCS, depressive symptoms, and capsaicin-induced secondary punctate hyperalgesia were assessed at baseline and weekly until an 18-week follow-up. Results Two of the three cases showed considerable improvement on all measures of symptoms and functional impairments related to MCS in response to PEMF therapy. One case showed no improvement and during the treatment period was unexpectedly diagnosed with depression. Conclusion Our findings indicate potential benefits of PEMF therapy in MCS. Implication The therapeutic effect of PEMF in MCS needs to be investigated by a randomized placebo-controlled trial.

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Pain
Vol/bind5
Udgave nummer2
Sider (fra-til)104-109
Antal sider6
ISSN1877-8860
DOI
StatusUdgivet - 1 apr. 2014

ID: 55209995